We are decentralizing the clinical lab to deliver universal, lab-grade diagnostics, accelerating time-to-action by 100x.
Biosens has raised $342K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2025.
Biosens's investors include VENTIUR, Bold Capital.
Biosens is headquartered in São Leopoldo, Brazil.
We are decentralizing the clinical lab to deliver universal, lab-grade diagnostics, accelerating time-to-action by 100x.
Biosens is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biosens — Funding & Investors." VCBacked, February 1, 2025, https://www.vcbacked.co/company/biosens. Accessed September 30, 2026.
VCBacked. (2025). Biosens — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biosens
{{cite web |title=Biosens — Funding & Investors |url=https://www.vcbacked.co/company/biosens |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated